| Primary |
| Product Used For Unknown Indication |
35.3% |
| Colitis Ulcerative |
17.6% |
| Angina Pectoris |
11.8% |
| Cardiac Failure |
8.8% |
| Depression |
8.8% |
| Dizziness |
2.9% |
| Gastritis |
2.9% |
| Hypertension |
2.9% |
| Insomnia |
2.9% |
| Osteoporosis |
2.9% |
| Spinal Osteoarthritis |
2.9% |
|
| Lung Disorder |
50.0% |
| Lymphocyte Stimulation Test Positive |
25.0% |
| Rhabdomyolysis |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
18.3% |
| Depression |
15.8% |
| Insomnia |
15.4% |
| Hypertension |
9.0% |
| Pain |
5.7% |
| Drug Use For Unknown Indication |
5.7% |
| Anxiety |
4.2% |
| Ill-defined Disorder |
4.1% |
| Schizophrenia |
3.2% |
| Constipation |
2.9% |
| Rheumatoid Arthritis |
2.2% |
| Gastric Ulcer |
2.1% |
| Suicide Attempt |
1.8% |
| Prophylaxis |
1.7% |
| Gastritis |
1.7% |
| Diabetes Mellitus |
1.4% |
| Fibromyalgia |
1.3% |
| Sleep Disorder Therapy |
1.3% |
| Anticoagulant Therapy |
1.2% |
| Infection |
1.1% |
|
| Hepatitis Acute |
13.1% |
| Hepatitis Fulminant |
9.7% |
| Interstitial Lung Disease |
8.2% |
| Rhabdomyolysis |
7.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
7.1% |
| Liver Disorder |
7.1% |
| Somnolence |
7.1% |
| Suicide Attempt |
5.2% |
| White Blood Cell Count Increased |
3.7% |
| Overdose |
3.4% |
| Thrombocytopenia |
3.4% |
| Tremor |
3.4% |
| Hepatic Function Abnormal |
3.0% |
| Vomiting |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
| Delirium |
2.6% |
| Pyrexia |
2.6% |
| Eosinophilic Pneumonia |
2.2% |
| Parkinsonism |
2.2% |
| Sepsis |
2.2% |
|
| Concomitant |
| Insomnia |
12.8% |
| Hypertension |
11.1% |
| Product Used For Unknown Indication |
9.9% |
| Prophylaxis |
8.6% |
| Drug Use For Unknown Indication |
8.4% |
| Depression |
8.1% |
| Rheumatoid Arthritis |
7.1% |
| Constipation |
5.4% |
| Hepatitis C |
3.5% |
| Gastritis |
3.4% |
| Schizophrenia |
2.9% |
| Osteoporosis |
2.7% |
| Pain |
2.4% |
| Anxiety |
2.4% |
| Parkinson's Disease |
2.3% |
| Chronic Hepatitis C |
2.2% |
| Diabetes Mellitus |
2.1% |
| Gastric Ulcer |
1.8% |
| Hyperlipidaemia |
1.7% |
| Asthma |
1.5% |
|
| White Blood Cell Count Decreased |
10.5% |
| Vomiting |
8.9% |
| Interstitial Lung Disease |
6.9% |
| Pyrexia |
6.9% |
| Pneumonia |
6.4% |
| Renal Impairment |
5.4% |
| Rash |
5.3% |
| Tremor |
5.3% |
| Rhabdomyolysis |
4.8% |
| Malaise |
4.4% |
| White Blood Cell Count Increased |
4.4% |
| Liver Disorder |
4.2% |
| Somnolence |
4.0% |
| Suicide Attempt |
4.0% |
| Platelet Count Decreased |
3.8% |
| Thrombocytopenia |
3.5% |
| Loss Of Consciousness |
3.2% |
| Weight Increased |
3.0% |
| Renal Failure Acute |
2.7% |
| Shock |
2.5% |
|
| Interacting |
| Upper Respiratory Tract Inflammation |
17.2% |
| Hypertension |
13.8% |
| Delirium |
10.3% |
| Constipation |
6.9% |
| Pain |
6.9% |
| Post Herpetic Neuralgia |
6.9% |
| Adrenal Insufficiency |
3.4% |
| Angina Pectoris |
3.4% |
| Asthma |
3.4% |
| Diarrhoea |
3.4% |
| Hepatic Cyst |
3.4% |
| Insomnia |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Reflux Oesophagitis |
3.4% |
| Renal Failure Chronic |
3.4% |
| Renal Transplant |
3.4% |
| Rhinitis Allergic |
3.4% |
|
| Drug Interaction |
20.0% |
| Haemodialysis |
20.0% |
| Somnolence |
20.0% |
| Tremor |
20.0% |
| Vith Nerve Disorder |
20.0% |
|
